Clinical Trial

Comparing the Garmin Venu 3 / Garmin Venu 4 for Non-Invasive Vital Sign Monitoring to a Hospital-Grade Monitor

Study acronym: GARMIN
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 24, 2026 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
Summary
This clinical trial evaluates the accuracy of the Garmin Venu 3 / Garmin Venu 4 smartwatch in measuring vital signs (heart rate, respiratory rate, SpO₂) compared to the clinically validated Philips IntelliVue X2. The study aims to determine whether the consumer-grade smartwatch can provide reliable data for remote patient monitoring, early hospital discharge, and chronic disease management, offering a more accessible and affordable alternative to MDR-certified devices.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-01-16.
Trial Details
NCT Number NCT07360678
Lead Sponsor Ziekenhuis Oost-Limburg
Conditions Validation of Vital Signs Measured by a Consumer-grade Smartwatch
Enrollment 30 participants
Start Date 2025-10-12
Primary Completion 2026-06 (estimated)
Study Completion 2026-06 (estimated)
Updated on ClinicalTrials.gov 2026-02-24